Stanford University


Showing 81-90 of 598 Results

  • Joshua Makower

    Joshua Makower

    Yock Family Professor and Professor of Bioengineering

    Current Research and Scholarly InterestsDr. Josh Makower is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Director of the Stanford Byers Center for Biodesign, the program he co-founded with Dr. Paul Yock twenty years ago. Josh helped create the fundamental structure of the Center’s core curriculum and is the chief architect of what is now called “The Biodesign Process.” Over the past 20 years since Josh and Paul founded Biodesign, this curriculum and the associated textbook has been used at Stanford and across the world to train hundreds of thousands of students, faculty and industry leaders on the Biodesign process towards the advancement of medical innovation for the improvement of patient care. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 9 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, NC8 and Willow. Josh is also a Special Partner at NEA where he supports the healthcare team and medtech/healthtech investing practice. Josh serves on the boards of Allay Therapeutics, Revelle Aesthetics, Setpoint Medical, DOTS Technologies, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering and the College of Fellows of The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.

  • Maryam S. Makowski, PhD

    Maryam S. Makowski, PhD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioMaryam Sarah Makowski, PhD, is a Clinical Associate Professor at Stanford University in the Department of Psychiatry and Behavioral Sciences. She also serves as the Associate Director of Scholarship and Health Promotion for the Stanford Medicine WellMD & WellPhD program. Additionally, she is a member of the Well-being Advisory Committee and represents Psychiatry and Behavioral Sciences as an alternate faculty senate member at Stanford Medicine.

    As a nutrition scientist, physician well-being expert, and National Board-Certified Health and Wellness Coach, Dr. Makowski provides well-being coaching to Stanford Medicine faculty, residents, and fellows as part of the WellConnect Program, and patients of the Lifestyle Psychiatry Clinic. She was honored with the 2024 Annual Chairman's Award for Clinical Innovation and Service in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.

    Using evidence-based strategies, Dr. Makowski empowers her clients to optimize their well-being, energy, focus, and mental sharpness for peak performance. Dr. Makowski's research on physician well-being includes studying the effects of individual factors such as lifestyle practices, self-compassion, and self-valuation on physician well-being. Her nutrition research focuses on examining the impact of micro- and macro-nutrients, meal composition, and timing on cognitive function, mood, mental sharpness, and eating behaviors of professionals with high cognitive and physical demands, particularly physicians.
    Maryam earned her master's and doctoral degrees in clinical nutrition, nutritional epidemiology, and medical science from the University of Toronto. Before joining Stanford, she worked as a scientific associate at Toronto General Hospital-University Health Network and served as an advisor to Air Canada rouge pilots and cabin crew for fatigue management. Throughout her career, Dr. Makowski has authored highly cited scientific papers related to nutrition and well-being, making significant contributions to the field.

  • Jose R. Maldonado, MD, FACLP, FACFE

    Jose R. Maldonado, MD, FACLP, FACFE

    John and Terry Levin Family Professor of Medicine and Professor, by courtesy, of Emergency Medicine and of Medicine

    Current Research and Scholarly InterestsPathophysiology and Management of Delirium, Acute Brain Failure and Cognitive Impairment, Neuropsychiatric Sequelae of Traumatic Brain Injury, Factitious Disorder & Munchausen's Syndrome, Cultural Diversity in Medical Care, Psychiatric Complications of Bone Marrow Transplantation, Conversion Disorder, Depression in the Medically Ill, Neuropsychiatric Sequelae of Chronic Fatigue Syndrome.

  • Yvonne Maldonado

    Yvonne Maldonado

    Senior Associate Dean, Faculty Development and Diversity, Taube Professor of Global Health and Infectious Diseases, Professor of Pediatrics (Infectious Diseases) and of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.

  • Robert Malenka

    Robert Malenka

    Nancy Friend Pritzker Professor of Psychiatry and Behavioral Sciences
    On Leave from 11/01/2023 To 10/31/2025

    Current Research and Scholarly InterestsLong-lasting changes in synaptic strength are important for the modification of neural circuits by experience. A major goal of my laboratory is to elucidate the molecular events that trigger various forms of synaptic plasticity and the modifications in synaptic proteins that are responsible for the changes in synaptic efficacy.